Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan P Schneider

Showing results (41-50 of 119) with videos related to

Pageof 12
Sort By:
Current Oncology Reports|December 15, 2023
Racial Disparities in Breast Cancer: from Detection to TreatmentJ C Chen, Daniel G Stover, Tarah J Ballinger, et al.
JAMA Network Open|February 28, 2022
Quality of Life Following Receipt of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast CancerShoshana M Rosenberg, Anne O'Neill, Karen Sepucha, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 22, 2013
A pharmacogenetics study to predict outcome in patients receiving anti-VEGF therapy in age related macular degenerationJohn W Kitchens, Nawal Kassem, William Wood, et al.
Breast Cancer Research and Treatment|March 4, 2014
Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103Kathryn J Ruddy, Anne O'Neill, Kathy D Miller, et al.
Plos One|May 13, 2014
Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusionKelly N H Nudelman, Yang Wang, Brenna C McDonald, et al.
The Lancet. Oncology|February 3, 2019
Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysisEverardo D Saad, Pierre Squifflet, Tomasz Burzykowski, et al.
The Annals of Thoracic Surgery|January 29, 2008
A 25-year single institution experience with surgery for primary mediastinal nonseminomatous germ cell tumorsKenneth A Kesler, Karen M Rieger, Zane T Hammoud, et al.
JAMA Oncology|June 27, 2015
Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast CancerAnn H Partridge, Karen Sepucha, Anne O'Neill, et al.
Breast Cancer Research and Treatment|September 12, 2008
Exploratory study evaluating the association of polymorphisms of angiogenesis genes with hot flashesBryan P Schneider, Milan Radovich, David A Flockhart, et al.
JCO Precision Oncology|January 16, 2018
Impact of Genetic Ancestry on Outcomes in ECOG-ACRIN-E5103Bryan P Schneider, Fei Shen, Guanglong Jiang, et al.
Pageof 12

Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
Current Oncology Reports|December 15, 2023
Racial Disparities in Breast Cancer: from Detection to TreatmentJ C Chen, Daniel G Stover, Tarah J Ballinger, et al.
JAMA Network Open|February 28, 2022
Quality of Life Following Receipt of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast CancerShoshana M Rosenberg, Anne O'Neill, Karen Sepucha, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 22, 2013
A pharmacogenetics study to predict outcome in patients receiving anti-VEGF therapy in age related macular degenerationJohn W Kitchens, Nawal Kassem, William Wood, et al.
Breast Cancer Research and Treatment|March 4, 2014
Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103Kathryn J Ruddy, Anne O'Neill, Kathy D Miller, et al.
Plos One|May 13, 2014
Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusionKelly N H Nudelman, Yang Wang, Brenna C McDonald, et al.
The Lancet. Oncology|February 3, 2019
Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysisEverardo D Saad, Pierre Squifflet, Tomasz Burzykowski, et al.
The Annals of Thoracic Surgery|January 29, 2008
A 25-year single institution experience with surgery for primary mediastinal nonseminomatous germ cell tumorsKenneth A Kesler, Karen M Rieger, Zane T Hammoud, et al.
JAMA Oncology|June 27, 2015
Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast CancerAnn H Partridge, Karen Sepucha, Anne O'Neill, et al.
Breast Cancer Research and Treatment|September 12, 2008
Exploratory study evaluating the association of polymorphisms of angiogenesis genes with hot flashesBryan P Schneider, Milan Radovich, David A Flockhart, et al.
JCO Precision Oncology|January 16, 2018
Impact of Genetic Ancestry on Outcomes in ECOG-ACRIN-E5103Bryan P Schneider, Fei Shen, Guanglong Jiang, et al.
Pageof 12